Company attributes
Location
Venture Capital Firm attributes
Invested in
Other attributes
Company Operating Status
Active
T&Brothers Capital is an asset management company that invested in Burning Rock, a company in China that focuses on providing individualized cancer treatment guidance for the patients. Using medical and bio informatics plus Next-Generation Sequencing (NGS) as the core technologies, Burning Rock offers a solution for clinical and R&D services concerning the genetic testing of individualized cancer treatment. In February 2015, T&Brothers Capital invested in the Series C round of Burning Rock Biotech. The amount funded was $125.5M, and the company coinvested with CMB International Capital, GIC, Lilly Asia Ventures, LYFE Capital, and Sequoia Capital China.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Associated Investment Funds
Accelerator Batches
Patents
Funding Rounds Participated In
Further Resources
No Further Resources data yet.
